DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20213190

Effect of laparoscopic ovarian drilling on serum anti-Mullerian hormone in clomiphene citrate resistant polycystic ovarian syndrome patients

Ambika Shankar, Oby Nagar, Shakuntla ., Suman Meghwal

Abstract


Background: PCOS (polycystic ovarian syndrome) is the most common cause of anovulatory infertility, the purpose of our study was to see the effect of laparoscopic ovarian drilling on the ovarian reserve (with AMH as an indicator of ovarian reserve) and its safety as 2nd line of treatment in patients resistant to clomiphene citrate.

Methods: This was a prospective interventional study conducted on 40 clomiphene citrate resistant PCOS women attending the infertility OPD. This study was conducted over a period of 1 year May 2019 to May 2020. Laparoscopic ovarian drilling (LOD) was done and these subjects were studied preoperatively and postoperatively on day 7 and day 30 for change in AMH (anti-Mullerian hormone) levels.

Results: There is a significant change in the AMH level post LOD day 7 and 30 but not so severe that it will lead to premature ovarian failure. The amount of drop in AMH (day 30) increases till 20 ng/ml beyond which it shows a decrease.

Conclusions: If LOD is done in a proper manner in women with sufficient ovarian reserve (high AMH), it will not adversely affect the ovarian reserve (the fall is not enough to cause premature ovarian insufficiency).

 


Keywords


PCOS, Anti-Mullerian hormone, Laparoscopic ovarian drilling

Full Text:

PDF

References


Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067-73.

Chang J, Azziz R, Legro R, Dewailley D, Franks S, Tarlatzis BC, et al. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004;81(1):19-25.

Balgen A. Polycystic ovary syndrome and secondary amenorrhoea. In: Edmonds DK, Lees C, Bourne T, eds. Dewhurt´s textbook of Obestetric and Gynaecology. 8th ed. John Wiley and Sons Ltd; 2012: 513-33.

Bhagavath B, Carson SA. Ovulation induction in women with polycystic ovary syndrome: an update. Am J Obstet Gynecol. 2012;206(3):195-8.

Badawy A, Mosbah A, Shady M. Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trail. Fertil Steril. 2008;89(5):1209-12.

Gadir AA, Mowafi RS, Alnaser HM, Alrashid AH, Alonezi OM, Shaw RW. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin Endocrinol (Oxf). 1990;33(5):585-92.

Marca AL, Broekmans FJ, Volpe A, Fauser BC, Macklon NS, ESHRE special interest group for reproductive endocrinology-AMH round table. Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod. 2009;24(9):2264-75.

Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, et al. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88(12):5957-62.

Lambert-Messerlian G, Plante B, Eklund EE, Raker C, Moore RG. 2016 Levels of antimüllerian hormone in serum during the normal menstrual cycle. Fertil Steril. 2016;105(1):208-13.

Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti Müllerian hormone: ovarian reserve testing and its potential clinical implication. Hum Reprod Update. 2014;20(5):688-701.

Weerakiet S, Lertvikool S, Tingthanatikul Y, Wansumrith S, Leelaphiwat S, Jultanmas R. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling. Gynecol Endocrinol. 2007;23(8):455-60.

Maheshwari A, Gibreel A, Bhattacharya S, Johnson N. Dynamic tests of ovarian reserve: a systematic review of diagnostic accuracy. Reprod Biomed Online. 2009;18(5):717-34.

Saraswat M, Jose T, Rajput M, Siddique N. Impact of laparoscopic ovarian drilling on anti-mullerian hormone levels in women with clomiphene resistant polycystic ovary syndrome. Indian J Obstet Gynecol Res. 2017;4(3):297-300.

Elmashad A. Impact of laparoscopic ovarian drilling on anti-Mullerian hormone levels and ovarian stromal blood flow using three dimensional power Doppler in women with anovulatory polycystic ovary syndrome. Fertil Steril. 2011;95(7):2342-6.

Amer S, Li TC, Ledger WL. Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. Hum Reprod. 2004;19(1):719-24.

Al-Assadi AF, Dhamia S. The effect of laparoscopic ovarian drilling on the serum levels of AMH, FSH, LH and testosterone hormones, in patients with PCOS. Med J Basrah Univ. 2019.

Paramu S. Impact of laparoscopic ovarian drilling on serum anti-Mullerian hormone levels in patients with anovulatory polycystic ovarian syndrome. Turk J Obstet Gynecol. 2016;13:203-7.

Farzadi L, Nouri M, Ghojazadeh M, Mohiti M, Aghadavod E. Evaluation of ovarian reserve after laparoscopic surgery in patients with polycystic ovary syndrome. Bio Impact. 2012;2(3):167-70.

Amer S, Li TC, Ledger WL. The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy. Hum Reprod. 2009;24(11):2760-6.

Kwee J, Schats R, McDonnell J, Themmen A, Jong F, Lambalk C. Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril. 2008;90(3):737-43.

Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, et al. Circulating basal anti- Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2009;92(5):1586-93.